CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.42B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.49: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.23%Above 5Y avg (4.16%)
Annual Rate
BRL 1.05Paid quarterly
Payout Ratio
41.8%Sustainable
Payback Period
23.7 yr
Last Ex-Dividend
Jun 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
17.53BBRL3.42B · vs all stocks (USD)
Trailing P/E
9.14xRevenue (TTM)
8.82BBRL1.72B · vs all stocks (USD)
Profit Margin
19.82%Beta
0.1090xvs all stocks
52-Week Change
6.89%vs all stocks
Forward Annual Dividend Yield
4.23%vs all stocks
Market Capitalization
17.53BBRL3.42B · vs all stocks (USD)
Enterprise Value
23.09BBRL4.50B · vs all stocks (USD)
Trailing P/E
9.14xForward P/E
7.50xPEG Ratio
1.71xPrice to Sales (TTM)
1.93xPrice to Book (MRQ)
1.18xEnterprise to Revenue
2.62xEnterprise to EBITDA
8.49xGross Margin
61.78%Profit Margin
19.82%Operating Margin
28.67%Return on Assets (TTM)
6.31%Return on Equity (TTM)
13.16%Revenue (TTM)
8.82BBRL1.72B · vs all stocks (USD)
Revenue per Share (TTM)
13.49BRLUpdated Sep 23, 2026Quarterly Revenue Growth
8.50%Gross Profit (TTM)
5.39BBRL1.05B · vs all stocks (USD)
EBITDA (TTM)
2.23BBRL435.53M · vs all stocks (USD)
Net Income (TTM)
1.74BBRL340.28M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
15.20%Operating Cash Flow (TTM)
2.90BBRL566.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
684.22MBRL133.46M · vs all stocks (USD)
Forward Annual Dividend Rate
1.05BRLUpdated Sep 23, 2026Forward Annual Dividend Yield
4.23%vs all stocks
Trailing Annual Dividend Rate
1.11BRLUpdated Sep 23, 2026Trailing Annual Dividend Yield
4.44%vs all stocks
5-Year Average Dividend Yield
4.16%vs all stocks
Payout Ratio
41.78%Minority Interest (Equity)
2.35MBRLFY2025 · Dec 31, 2025Revenue
7.70BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
3.15BBRLFY2025 · Dec 31, 2025Gross Profit
4.55BBRLFY2025 · Dec 31, 2025Operating Income
1.74BBRL339.02M · vs all stocks (USD)
Pre-tax Income
900.07MBRLFY2025 · Dec 31, 2025Income Tax Expense
-290.75MBRLFY2025 · Dec 31, 2025Net Income
1.19BBRLFY2025 · Dec 31, 2025EBIT
1.94BBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.23BBRLFY2025 · Dec 31, 2025Research & Development
134.73MBRLFY2025 · Dec 31, 2025Selling, General & Administrative
2.27BBRLFY2025 · Dec 31, 2025Other Operating Expenses
10.53MBRLFY2025 · Dec 31, 2025Non-operating Interest Income
47.59MBRLFY2025 · Dec 31, 2025Non-operating Interest Expense
1.04BBRLFY2025 · Dec 31, 2025EPS (Basic)
1.89BRLFY2025 · Dec 31, 2025EPS (Diluted)
1.89BRLFY2025 · Dec 31, 2025Basic Shares Outstanding
632.62MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
632.62MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
5.24MBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
2.02BBRLFY2025 · Dec 31, 2025Free Cash Flow
1.50BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.65BBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
899.18MBRLFY2025 · Dec 31, 2025Stock-based Compensation
22.98MBRLFY2025 · Dec 31, 2025Other Non-cash Items
892.38MBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
566.32MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-357.48MBRLFY2025 · Dec 31, 2025Capital Expenditures
-523.22MBRLFY2025 · Dec 31, 2025Net Intangibles (CF)
-276.15MBRLFY2025 · Dec 31, 2025Net Acquisitions
-28.97MBRLFY2025 · Dec 31, 2025Other Investing Activity
-9.05MBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
-561.24MBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
3.12BBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-3.36BBRLFY2025 · Dec 31, 2025Common Stock Repurchase
-23.09MBRLFY2025 · Dec 31, 2025Common Dividends Paid
-627.78MBRLFY2025 · Dec 31, 2025Other Financing Charges
49.16MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
-831.35MBRLFY2025 · Dec 31, 2025Shares Outstanding
703.99MSharesUpdated Sep 23, 2026Float Shares
305.73MSharesUpdated Sep 23, 2026% Held by Insiders
56.57%vs all stocks
% Held by Institutions
33.23%vs all stocks
Total Cash (MRQ)
1.58BBRL307.90M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.24BRLUpdated Sep 23, 2026Total Debt (MRQ)
7.69BBRL1.50B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5329xCurrent Ratio (MRQ)
1.86xBook Value per Share (MRQ)
20.50BRLUpdated Sep 23, 2026Total Assets
25.16BBRL4.91B · vs all stocks (USD)
Total Current Assets
6.05BBRLFY2025 · Dec 31, 2025Total Liabilities
12.63BBRLFY2025 · Dec 31, 2025Total Non-current Assets
19.11BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
8.52BBRLFY2025 · Dec 31, 2025Total Current Liabilities
4.11BBRLFY2025 · Dec 31, 2025Cash
10.10MBRLFY2025 · Dec 31, 2025Cash Equivalents
1.64BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.65BBRLFY2025 · Dec 31, 2025Accounts Receivable
1.69BBRLFY2025 · Dec 31, 2025Inventory
2.08BBRLFY2025 · Dec 31, 2025Accounts Payable
1.07BBRLFY2025 · Dec 31, 2025Short-term Debt
1.33BBRLFY2025 · Dec 31, 2025Other Current Liabilities
432.38MBRLFY2025 · Dec 31, 2025Long-term Debt
8.01BBRLFY2025 · Dec 31, 2025Other Non-current Liabilities
173.26MBRLFY2025 · Dec 31, 2025Common Stock (Book)
9.71BBRLFY2025 · Dec 31, 2025Total Shareholders' Equity
12.52BBRL2.44B · vs all stocks (USD)
Treasury Stock
12.39MBRLFY2025 · Dec 31, 202552-Week Low
19.88BRLUpdated Sep 23, 202652-Week High
27.79BRLUpdated Sep 23, 202652-Week Change
6.89%vs all stocks
Beta
0.1090xvs all stocks
50-Day MA
21.70BRLUpdated Sep 23, 2026200-Day MA
22.48BRLUpdated Sep 23, 2026Avg 10-Day Volume
3.10MSharesUpdated Sep 23, 2026Avg 30-Day Volume
3.16MSharesUpdated Sep 23, 2026Diluted EPS (TTM)
2.64BRLUpdated Sep 23, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.49: grey zoneSignificant
Altman Z-Score: 1.49
High earnings qualityNotable
Earnings Quality Score: 0.88
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.42B, above the global median of $1.15BNotable
Market cap (USD): 3,419,304,129.362Global Median: 1,150,342,212.262
Revenue is $1.72B, above the global median of $559.35MNotable
Revenue (USD): 1,720,193,455.165Global Median: 559,350,010.583
Levered free cash flow is $133.46M, above the global median of $18.98MNotable
Levered free cash flow (USD): 133,463,510.024Global Median: 18,979,762.15
Companies that share the same coordination system — how they create, deliver, or capture value.
Laboratorios Farmacéuticos Rovi SA
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arcutis Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hybio Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Nhwa Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tarsus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xenon Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule